What is NuSkin Enterprises's stock-based comp?

NuSkin Enterprises (NUS) reported stock-based comp of $3.7M in Q1 2026.

How has NuSkin Enterprises's stock-based comp changed year-over-year?

NuSkin Enterprises's stock-based comp decreased by 60.3% year-over-year, from $9.31M to $3.7M.

Over 4 years (2021 to 2025), NuSkin Enterprises's stock-based comp has grown at a 1.0% compound annual growth rate (CAGR), from $23.19M to $24.11M.

USANA Health SciencesUSNA

——

HerbalifeHLF

——

The Beauty Health CompanySKIN

——

Celsius Holdings, Inc.CELH

——

Revenue$320.6M-12.0%

Gross profit$214.5M-13.2%

Operating income$4.0M+141%

Net income$1.8M-98.3%

EPS (diluted)$0.04-98.1%

Cash & equivalents$198.7M-2.5%

Total debt$303.6M-8.2%

Total equity$794.1M+5.3%

Total assets$1.4B-1.1%

Operating cash flow-$3.9M-1,107%

CapEx$13.7M+1.0%

Free cash flow-$17.6M-33.6%

Market cap$256.35M-38.2%

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is NuSkin Enterprises's stock-based comp?: NuSkin Enterprises (NUS) reported stock-based comp of $3.7M in Q1 2026.
How has NuSkin Enterprises's stock-based comp changed year-over-year?: NuSkin Enterprises's stock-based comp decreased by 60.3% year-over-year, from $9.31M to $3.7M.
What is the long-term trend for NuSkin Enterprises's stock-based comp?: Over 4 years (2021 to 2025), NuSkin Enterprises's stock-based comp has grown at a 1.0% compound annual growth rate (CAGR), from $23.19M to $24.11M.